Literature DB >> 21609021

Mass spectrometric determination of IgG subclass-specific glycosylation profiles in siblings discordant for myositis syndromes.

Irina Perdivara1, Shyamal D Peddada, Frederick W Miller, Kenneth B Tomer, Leesa J Deterding.   

Abstract

Many autoimmune conditions are believed to result from chronic inflammation as a consequence of the interaction of genetic and environmental factors in susceptible individuals. One common feature in some autoimmune diseases is the decrease in terminal galactosylation of the constant region N-glycan of the total plasma immunoglobulin. To determine whether a similar pattern is characteristic for the autoimmune disorder myositis, we analyzed the antibody subclass specific glycosylation in patients with myositis, their asymptomatic siblings, and healthy unrelated age- and sex-matched controls. The antibody subclass specific glycosylation was determined from the LC-MS analyses of the IgG glycopeptides generated by trypsin digestion of the antibody heavy chain. The glycosylation profiles of the IgG subclasses were determined relative to the total abundance of all glycoforms. We found elevated amounts of glycoforms lacking terminal galactose in myositis patients. Pairwise statistical analyses reveals that galactosylation is statistically different between the myositis patients and control groups. Furthermore, the trend analysis for glycosylation indicates a pattern of decreasing galactosylation in the order controls ≥ siblings ≥ myositis patients, suggesting the existence of a genetic, immune-related predisposition in the group of asymptomatic siblings that can be detected before the onset of clinical symptoms at the level of plasma proteins.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21609021      PMCID: PMC3137520          DOI: 10.1021/pr200397h

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  53 in total

Review 1.  Recent insights into the genetic basis of systemic lupus erythematosus.

Authors:  K L Moser; J A Kelly; C J Lessard; J B Harley
Journal:  Genes Immun       Date:  2009-05-14       Impact factor: 2.676

Review 2.  IgG glycosylation analysis.

Authors:  Carolin Huhn; Maurice H J Selman; L Renee Ruhaak; André M Deelder; Manfred Wuhrer
Journal:  Proteomics       Date:  2009-02       Impact factor: 3.984

3.  DNA methylation profiles in monozygotic and dizygotic twins.

Authors:  Zachary A Kaminsky; Thomas Tang; Sun-Chong Wang; Carolyn Ptak; Gabriel H T Oh; Albert H C Wong; Laura A Feldcamp; Carl Virtanen; Jonas Halfvarson; Curt Tysk; Allan F McRae; Peter M Visscher; Grant W Montgomery; Irving I Gottesman; Nicholas G Martin; Art Petronis
Journal:  Nat Genet       Date:  2009-01-18       Impact factor: 38.330

4.  Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.

Authors:  Robert M Anthony; Falk Nimmerjahn; David J Ashline; Vernon N Reinhold; James C Paulson; Jeffrey V Ravetch
Journal:  Science       Date:  2008-04-18       Impact factor: 47.728

5.  Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies.

Authors:  Terrance P O'Hanlon; Lisa G Rider; Adam Schiffenbauer; Ira N Targoff; Karen Malley; Janardan P Pandey; Frederick W Miller
Journal:  Arthritis Rheum       Date:  2008-10

6.  Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies.

Authors:  Johan Rönnelid; Sevim Barbasso Helmers; Helena Storfors; Katarina Grip; Lars Rönnblom; Karin Franck-Larsson; Gunnel Nordmark; Ingrid E Lundberg
Journal:  Autoimmun Rev       Date:  2009-03-11       Impact factor: 9.754

7.  A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.

Authors:  L A Love; R L Leff; D D Fraser; I N Targoff; M Dalakas; P H Plotz; F W Miller
Journal:  Medicine (Baltimore)       Date:  1991-11       Impact factor: 1.889

8.  Elucidation of O-glycosylation structures of the beta-amyloid precursor protein by liquid chromatography-mass spectrometry using electron transfer dissociation and collision induced dissociation.

Authors:  Irina Perdivara; Robert Petrovich; Bernadette Allinquant; Bernadette Alliquant; Leesa J Deterding; Kenneth B Tomer; Michael Przybylski
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

9.  Glycosylation profiles of epitope-specific anti-beta-amyloid antibodies revealed by liquid chromatography-mass spectrometry.

Authors:  Irina Perdivara; Leesa J Deterding; Claudia Cozma; Kenneth B Tomer; Michael Przybylski
Journal:  Glycobiology       Date:  2009-03-24       Impact factor: 4.313

Review 10.  Glycosylation of serum proteins in inflammatory diseases.

Authors:  Olga Gornik; Gordan Lauc
Journal:  Dis Markers       Date:  2008       Impact factor: 3.434

View more
  15 in total

Review 1.  A case for protein-level and site-level specificity in glycoproteomic studies of disease.

Authors:  Katherine N Schumacher; Eric D Dodds
Journal:  Glycoconj J       Date:  2016-03-23       Impact factor: 2.916

Review 2.  Potential of glycosylation research in graft versus host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  Ema Prenc; Drazen Pulanic; Maja Pucic-Bakovic; Marija Pezer; Lana Desnica; Radovan Vrhovac; Damir Nemet; Steven Z Pavletic
Journal:  Biochim Biophys Acta       Date:  2016-02-26

3.  Site-Specific Glycan Heterogeneity Characterization by Hydrophilic Interaction Liquid Chromatography Solid-Phase Extraction, Reversed-Phase Liquid Chromatography Fractionation, and Capillary Zone Electrophoresis-Electrospray Ionization-Tandem Mass Spectrometry.

Authors:  Yanyan Qu; Liangliang Sun; Zhenbin Zhang; Norman J Dovichi
Journal:  Anal Chem       Date:  2018-01-03       Impact factor: 6.986

4.  Immunoglobulin G Glycosylation Changes in Aging and Other Inflammatory Conditions.

Authors:  Fabio Dall'Olio; Nadia Malagolini
Journal:  Exp Suppl       Date:  2021

Review 5.  The role of protein glycosylation in muscle diseases.

Authors:  Kai Dang; Shanfeng Jiang; Yuan Gao; Airong Qian
Journal:  Mol Biol Rep       Date:  2022-04-15       Impact factor: 2.742

6.  Glycosylation of Anti-Thyroglobulin IgG1 and IgG4 Subclasses in Thyroid Diseases.

Authors:  Yuan Li; Chenxu Zhao; Keli Zhao; Nan Yu; Yan Li; Yang Yu; Yang Zhang; Zhijing Song; Youyuan Huang; Guizhi Lu; Ying Gao; Junqing Zhang; Xiaohui Guo
Journal:  Eur Thyroid J       Date:  2020-08-27

7.  Aleuria Aurantia Lectin (AAL)-reactive immunoglobulin G rapidly appears in sera of animals following antigen exposure.

Authors:  Songming Chen; Chen Lu; Hongbo Gu; Anand Mehta; Jianwei Li; Patrick B Romano; David Horn; D Craig Hooper; Carthene R Bazemore-Walker; Timothy Block
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

8.  Changes in anti-thyroglobulin IgG glycosylation patterns in Hashimoto's thyroiditis patients.

Authors:  Shanshan Yuan; Qianqian Li; Yang Zhang; Chuncui Huang; Hongmei Wu; Yan Li; Yalei Liu; Nan Yu; Hong Zhang; Guizhi Lu; Yanming Gao; Ying Gao; Xiaohui Guo
Journal:  J Clin Endocrinol Metab       Date:  2014-11-07       Impact factor: 5.958

9.  Disease-specific IgG Fc N-glycosylation as personalized biomarkers to differentiate gastric cancer from benign gastric diseases.

Authors:  Dan Zhang; Bingchao Chen; Yanmin Wang; Peng Xia; Chengyan He; Yujie Liu; Ruiqing Zhang; Mo Zhang; Zhili Li
Journal:  Sci Rep       Date:  2016-05-13       Impact factor: 4.379

Review 10.  Human plasma protein N-glycosylation.

Authors:  Florent Clerc; Karli R Reiding; Bas C Jansen; Guinevere S M Kammeijer; Albert Bondt; Manfred Wuhrer
Journal:  Glycoconj J       Date:  2015-11-10       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.